Bridget Martell - Oct 18, 2023 Form 3/A - Amendment Insider Report for Ayala Pharmaceuticals, Inc. (ADXS)

Role
Director
Signature
/s/ Roy Golan, as attorney-in-fact for the Reporting Person
Stock symbol
ADXS
Transactions as of
Oct 18, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
11/3/2023, 11:43 AM
Date Of Original Report
Nov 1, 2023
Previous filing
Jul 21, 2023
Next filing
Jan 29, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney